Trial Profile
Valganciclovir Dosing in Pediatric Solid Organ Transplant Recipients - a Prospective Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Apr 2017
Price :
$35
*
At a glance
- Drugs Valganciclovir (Primary)
- Indications Cytomegalovirus infections
- Focus Pharmacokinetics
- 12 Apr 2017 New trial record
- 05 Apr 2017 Results published in the Pediatric Infectious Disease Journal